Please login to the form below

Not currently logged in
Email:
Password:

Obizur

This page shows the latest Obizur news and features for those working in and with pharma, biotech and healthcare.

Shire and Baxalta drugs among CHMP's latest recommendations

Shire and Baxalta drugs among CHMP's latest recommendations

The EMA advisers backed Shire's Intuniv (guanfacine) and Obizur (susoctocog alfa) from Baxalta for European approval. ... Baxalta's Obizur for the treatment of bleeding episodes in patients with acquired haemophilia caused by antibodies to factor VIII.

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics